The 340B Drug Pricing Program was originally constructed so safety-net health care facilities could stretch scarce resources in caring for low-income patients. However, the program has experienced exponential growth beyond its original, limited scope. This growth has had the simultaneous effect of decreasing health care affordability and increasing administrative complexity.It does not have to be […]
